Intervacc is trading 4.5% up today at €0.10, extending a sharp rebound seen over the past week. - The company announced its first export of Strangvac vaccine to New Zealand under a Special Circumstances Permit, following strangles outbreaks in the region. - This approval allows an initial supply of 1,200 vials and follows a request from the New Zealand Equine Health Association.